$19.21
1.16% today
NYSE, Aug 12, 09:15 pm CET
ISIN
US4270965084
Symbol
HTGC

Hercules Capital Stock price

$19.43
+0.49 2.59% 1M
-1.30 6.27% 6M
-0.52 2.58% YTD
+1.14 6.22% 1Y
+4.75 32.36% 3Y
+8.82 83.17% 5Y
+8.64 80.04% 10Y
+7.11 57.77% 20Y
NYSE, Closing price Mon, Aug 11 2025
-0.06 0.31%
ISIN
US4270965084
Symbol
HTGC
Industry

Key metrics

Basic
Market capitalization
$3.5b
Enterprise Value
$5.5b
Net debt
$2.0b
Cash
$52.3m
Shares outstanding
181.7m
Valuation (TTM | estimate)
P/E
14.2 | 10.0
P/S
7.0 | 6.7
EV/Sales
11.0 | 10.5
EV/FCF
negative
P/B
1.6
Dividends
DPS
$1.97
Yield 1Y | 5Y
8.5% | 9.3%
Growth 1Y | 5Y
8.3% | 7.8%
Payout 1Y | 3Y
122.1% | 120.0%
Increased
7 Years
Financials (TTM | estimate)
Revenue
$504.0m | $529.7m
EBITDA
$330.9m | -
EBIT
$330.5m | -
Net Income
$261.6m | $354.3m
Free Cash Flow
$-303.8m
Growth (TTM | estimate)
Revenue
-17.0% | 7.3%
EBITDA
-18.1% | -
EBIT
-18.1% | -
Net Income
-29.2% | 36.2%
Free Cash Flow
-81.8%
Margin (TTM | estimate)
Gross
81.7%
EBITDA
65.7% | -
EBIT
65.6%
Net
51.9% | 66.9%
Free Cash Flow
-60.3%
Financial Health
Equity Ratio
51.9%
Return on Equity
13.1%
ROCE
7.8%
ROIC
-
Debt/Equity
1.0
More
EPS
$1.4
FCF per Share
$-1.7
Short interest
2.9%
Employees
100
Rev per Employee
$4.9m
Show more

Is Hercules Capital a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Hercules Capital Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Hercules Capital forecast:

11x Buy
79%
3x Hold
21%

Analyst Opinions

14 Analysts have issued a Hercules Capital forecast:

Buy
79%
Hold
21%

Financial data from Hercules Capital

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
504 504
17% 17%
100%
- Direct Costs 92 92
8% 8%
18%
412 412
19% 19%
82%
- Selling and Administrative Expenses 93 93
20% 20%
18%
- Research and Development Expense - -
-
-
331 331
18% 18%
66%
- Depreciation and Amortization 0.35 0.35
5% 5%
0%
EBIT (Operating Income) EBIT 331 331
18% 18%
66%
Net Profit 262 262
29% 29%
52%

In millions USD.

Don't miss a Thing! We will send you all news about Hercules Capital directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hercules Capital Stock News

Negative
Seeking Alpha
3 days ago
We take a look at the action in business development companies through the first week of August and highlight some of the key themes we are watching. BDCs underperformed despite strong early earnings, with sector valuations dipping below historical averages. Tight lending spreads continue to pressure BDC net income.
Positive
Seeking Alpha
4 days ago
Business Development Companies offer income-focused investors access to big-yield private credit opportunities, traded on the public market. Hercules Capital is a standout among the group for its differentiated strategy, consistent long-term growth, and big quarterly dividend payments to investors. This report reviews Hercules' business strategy, growth, dividend safety, valuation, and risks, a...
Neutral
PRNewsWire
4 days ago
CARY, N.C. , Aug. 8, 2025 Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring designed to enhance the Company's financial flexibility, reduce total debt, and support long-term growth. The multi-faceted refinancing transaction consisted of the following key components...
More Hercules Capital News

Company Profile

Head office United States
CEO Scott Bluestein
Employees 100
Founded 2003
Website www.htgc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today